Preview

Трансплантология

Расширенный поиск

Нарушение метаболизма глюкозы после трансплантации органов

https://doi.org/10.23873/2074-0506-2009-0-2-9-14

Полный текст:

Аннотация

Описаны механизмы влияния на углеводный обмен иммуносупрессивных препаратов, а также факторы риска развития посттрансплантационного сахарного диабета и его осложнений.

Об авторах

М. Ш. Хубутия
МГМСУ
Россия
Кафедра трансплантологии и искусственных органов


О. Н. Ржевская
МГМСУ
Россия
Кафедра трансплантологии и искусственных органов


К. Е. Лазарева
МГМСУ
Россия

Кафедра трансплантологии и искусственных органов

Ксения Евгеньевна Лазарева 



Список литературы

1. Hathaway D.K., Tolley E.A., Blakely M.L. et al. Development of an index to predict post-transplant diabetes mellitus. Clin Transplant 1994;7:330—8.

2. Friedman E.A., Shyh T., Beyer M.M. et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985;5: 196—202.

3. Vincenti F., Friman S., Scheuermann E. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transp 2007;7:1506—14.

4. Howard A. Management of new-onset diabetes mellitus in the kidney transplant recipient. Medscape Transplant 2004; 14 Jul.

5. Thomas M.C, Moran J., Mathew T.H. et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrology 2000;1:1.

6. Pourmand G., Ebrahimi M.R., Mehrsai A.R., Taheri M. Patient blood glucose levels before and after kidney transplantation. Transplant Proc 2000;32(3):566—8.

7. Min C., Kang E., Yu S.H. et al. Advanced glycation end products induce apoptosis and pro-coagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract 1999;46(3): 197—202.

8. Pavlovic D., Van de Winkel M., Van der Auwera B. et al. Effect of interferongamma and glucose on major histo-compatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab 1997;82(7):2329—36.

9. Foster K.J., Alberti K.G., Binder C. et al. Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg 1979;66(4):242—5.

10. Spencer C.M., Goa K.L., Gillis J.C. Tacrolimus: an update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997;54: 925—75.

11. Jindal R.M., Sidner R.A., Milgrom M.L. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997;16: 242—57.

12. Pirsch J.D., Miller J., Deierhoi M.H. et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997;63:977—83.

13. Cavaille-Coll M.W., Elashoff M.R. Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1998;65:142—3.

14. Marchetti P., Navalesi R. The metabolic effects of cyclosporine and tacrolimus. J Endocrinol Invest 2000;23:482—90.

15. Heisel O., Heisel R., Balshaw R., Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004;4;583—95.

16. Jain A., Khanna A., Molmenti E.P. et al. Immunosuppressive therapy. Surg Clin North Am 1999;79:59—76.

17. Johnson C., Ahsan N., Gonwa T. et al. Randomized trial of tacrolimus in combination with azathioprine or mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000;63;834—41.

18. Lazzaro C., McKechnie T., McKenna M. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses. J Nephrol 2002;15:580—8.

19. Vincenti F., Jensik S.C., Filo R.S. et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002;73:775—82.

20. Weir M.R., Fink J.C. Risk for post-transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999;34:1—13.

21. Hirano Y., Fujihira S., Ohara K. et al. Morphological and functional changes of islets of Langherans in FK506-treated rats. Transplantation 1992;53:889—94.

22. Martin F., Bedoya F.J. Mechanisms of action of cyclosporine A on islet alfa-and beta cells. Effects on cAMP and calcium dependent pathways. Life Sci 1991;49:1915—21.

23. Redmond J.B., Olson L.K., Armstrong M.B. et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996;98: 2786—93.

24. Ishizuka J., Guiuzza K.K., Wassmuth Z. et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islet. Transplantation 1993;56:1486—90.

25. Noguchi N., Takasawa S., Nata K. et al. Cyclic ADP-ribose binds to FK506 binding protein 12.6 to release calcium++ from islet microsome. J Biol Chem 1997;272:3133—6.

26. Lanerolle R.D., de Abrew K., Fernando D.J., Sheriff M.H. Posttransplant diabetes in Sri Lanka. Transplant Proc 1996;28:1945—7.

27. Berwerck S., Kahl A., Bechstein W. et al. Clinical use of the euglicemic hyperinsulinemic clamp for diagnosis of tacrolimusinduced insulin resistance after combined pancreas-kidney transplantation. Transplant Proc 1998;30:1944—5.

28. Basadonna G., Montorsi F., Dakizaki K., Merrell R.C. Cyclosporine A and islet function. Am J Surg 1988;156:191—3.

29. Bani Sacchi T., Bani D., Filipponi F. et al. Immunocytochemical and ultra structural changes of islet cells in rats treated longterm with cyclosporine at immunotherapeutic doses. Transplantation 1990;49:982—7.

30. Van Hoff J.P., Christiaans M.H., Ven Duijnhoven E.M. et al. Glucose metabolic disorder after transplantation. Am J Transplant 2007;7:1435—6.

31. Ciancio G., Burke G., Gaynor J. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Transplantation 2004;77:252—8.

32. Maes B.D., Kuypers D., Messian T. et al. Post-transplan-tation diabetes mellitus in FK506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001;72:1655—61.

33. Pagano G., Cavalco-Perin P., Cassader M. et al. An in vivo and in vitro study of the mechanism of prednisoneinduced insulin resistance in healthy subjects. J Clin Invest 1983;72:1814—20.

34. Shapiro R., Jordan M.L., Scantlebury V.P. et al. A prospective, randomized trial of FK506/prednisone vs FK506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995;27:814—7.

35. Christiansen E., Andersen H., Rasmusse K. et al. Pancreatic b-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Am Physiol Soc 1993;264(3):441—9.

36. Andrews R.C., Wolker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999;96:513—23.

37. Henriksen J.E., Alford F., Ward G.M., Beck-Nielsen H. Risk and mechanism for dexamethazone-induced deterioration of glucose tolerance in non-diabetic first degree relatives of NIDDM patients. Diabetologia 1997;40:1439—48.

38. Hjelmesaeth J., Hartmann A., Kosstad J. et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997;64:979—83.

39. Jawad F., Rizvi S.A. Post-transplant diabetes mellitus in live-re-lated renal transplantation. Transplant Proc 2000;32:1888.

40. Boots J.M., Van Duijnhoven E.M., Christiaans M.H. et al. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002;13:221—7.

41. Vanrenterghem Y. Strategies to reduce or replace steroid dosing. Transplant Proc 1999;31 (Suppl 8A):7—10.

42. Christiansen E., Tibell A., Volund A.A. et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997;82:2299—307.

43. Gruessner R.W. Tacrolimus in pancreas transplantation: a multi-center analysis. Tacrolimus Pancreas Study Group. Clin Transplant 1997;11:299—312.

44. Gruessner R.W., Burke G.W., Stratta R. et al. A multi-center analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996;61:261—73.

45. Sumrani N.B., Delaney V., Ding Z. et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 1991;51:343—7.

46. Rao M., Jacob C.K., Shastry J.C. Post-renal transplant diabetes mellitus: a retrospective study. Nephrol Dial Transplant 1992;7:1039—42.

47. Keen H., Jarret R.J., Mc Cartney P. The ten-year follow-up of the Bedford survey (1962—1972): glucose tolerance and diabetes. Diabetologia 1982;22:73—8.

48. Vesco L., Busson M., Bedrossian J. et al. Diabetes mellitus after renal transplantation. Transplantation 1996;61:1475—8.

49. Kasiske B.L., Sneyder J.J., Gilbertson D., Matas A.J. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2002;2(Suppl 3):225.

50. Knoll G.A., Bell R.C. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. Br Med J 1999;318:1104—7.

51. Parikh C., Klem P., Wong C., Chan L. Obesity as an independent predictor of posttransplant diabetes mellitus (PTDM). Am J Transplant 2002;2(Suppl 3):420.

52. De Mattos A.M., Prather J., Al-Uzri A. et al. Autosomal dominant polycystic kidney disease (ADPKD) as risk factor for the development of posttransplant diabetes mellitus (PTDM). Am J Transplant 2002;2:359.

53. Cosio F.G., Pesavento T.E., Kim S. et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62:1440—6.

54. Revanur V.K., Jardine A.G., Kingsmore D.B. et al. Influence of diabetes mellitus on patients and graft survival in recipients of kidney transplantation. Clin Transplant 2001;15:89—94.

55. Thomas M.C., Mathew P.H., Russ G.R. et al. Early perioperative glycemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001;72:1321—4.

56. Klahr S., Levey A.S., Beck G.J. et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 1994;330:877—84.

57. Noble N.A., Border W.A. Angiotensin II in renal fibrosis. Should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 1997;17:455—66.

58. Miles A.M., Sumrani N., Horowitz R. et al. Diabetes mellitus after renal transplantation. Transplantation 1998;65:380—4.

59. Schneider D.J., Nordt T.K., Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993;42:1—7.

60. Maser R.E., Wolfson S.K. Jr., Ellis D. et al. Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Arterioscler Thromb 1991;11:958—65 [Abstract].

61. Laakso M., Pyorala K., Scarlund H., Voutilainen E. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus. Arteriosclerosis 1986;6:679— 84 [Abstract].

62. Raine A.E.G. Cardiovascular complications after renal transplantation. In: P.J. Morris (ed.). Kidney transplantation: principles and practice. Philadelphia: PA, Saunders; 1988. p. 575—601.

63. Hjelmeseth J., Hartmann A., Midvedt K. et al. Metabolic cardiovascular syndrome after renal Transplantation. Nephrol Dial Transplant 2001;16:1047—52.

64. Von Kiparsky A., Frei D., Uhlschmid G. et al. Post-transplant diabetes mellitus in renal allograft recipients: a matched pair control study. Nephrol Dial Transplant 1990;5:220—5.

65. Chiu M.Y., Sprague S.M., Bruce D.S. et al. Analysis of fracture prevalence in kidneypancreas allograft recipients. J Am Soc Nephrol 1998;9:677—83.

66. Marchetti P. Strategies for risk reduction and management of post-transplant diabetes mellitus. Transplant Proc 2001;33(Suppl 5A):27—31.


Для цитирования:


Хубутия М.Ш., Ржевская О.Н., Лазарева К.Е. Нарушение метаболизма глюкозы после трансплантации органов. Трансплантология. 2009;(2):9-14. https://doi.org/10.23873/2074-0506-2009-0-2-9-14

For citation:


Khubutia M.S., Rzhevskaya O.N., Lazareva K.E. Impaired glucose metabolism after organ transplantation. Transplantologiya. The Russian Journal of Transplantation. 2009;(2):9-14. (In Russ.) https://doi.org/10.23873/2074-0506-2009-0-2-9-14

Просмотров: 56


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2074-0506 (Print)
ISSN 2542-0909 (Online)